Cargando…

PROPERTIES OF SYNOVIAL CELLS IN CULTURE

Derangements of synovial membranes and cartilage occur early in the course of rheumatoid arthritis. These important alterations of the joint tissues are probably the in vivo reflections of complicated inflammatory and immunological events. In our laboratory we have been interested in studying altera...

Descripción completa

Detalles Bibliográficos
Autor principal:	Smith, Carol A.
Formato:	Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 1971
Materias:	Rheumatoid Arthritis and Other Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2139097/ https://www.ncbi.nlm.nih.gov/pubmed/19867375

Ejemplares similares

IMMUNOHISTOLOGIC STUDIES OF SYNOVIOCYTES AND SYNOVIAL EXUDATE CELLS
por: Hurd, Eric R., et al.
Publicado: (1971)

IMMUNOREACTANTS IN RHEUMATOID SYNOVIAL EFFUSIONS
por: Zvaifler, Nathan J.
Publicado: (1971)

Synovial fibroblasts in 2017
por: Ospelt, Caroline
Publicado: (2017)

Role of synovial fibroblast subsets across synovial pathotypes in rheumatoid arthritis: a deconvolution analysis
por: Micheroli, Raphael, et al.
Publicado: (2022)

Synovial tissue macrophages: friend or foe?
por: Kurowska-Stolarska, Mariola, et al.
Publicado: (2017)

MicroRNAs interfere with DNA methylation in rheumatoid arthritis synovial fibroblasts
por: Gaur, Niharika, et al.
Publicado: (2016)

Anticitrullinated protein antibodies facilitate migration of synovial tissue-derived fibroblasts
por: Sun, Meng, et al.
Publicado: (2019)

Allele-specific protein binding within the CD40 locus in human synovial fibroblasts and immune cells
por: Moser, Larissa, et al.
Publicado: (2023)

Release of Active Peptidyl Arginine Deiminases by Neutrophils Can Explain Production of Extracellular Citrullinated Autoantigens in Rheumatoid Arthritis Synovial Fluid
por: Spengler, Julia, et al.
Publicado: (2015)

Inclusion of Synovial Tissue–Derived Characteristics in a Nomogram for the Prediction of Treatment Response in Treatment‐Naive Rheumatoid Arthritis Patients
por: Alivernini, Stefano, et al.
Publicado: (2021)

Synovial cellular and molecular signatures stratify clinical response to csDMARD therapy and predict radiographic progression in early rheumatoid arthritis patients
por: Humby, Frances, et al.
Publicado: (2019)

Fibrocytes in early and long-standing rheumatoid arthritis: a 6-month trial with repeated synovial biopsy, imaging and lung function test
por: Just, Søren Andreas, et al.
Publicado: (2021)

Systematic Review and Appraisal of the Cross‐Cultural Validity of Functional Status Assessment Measures in Rheumatoid Arthritis
por: Kulhawy‐Wibe, Stephanie C., et al.
Publicado: (2020)

Use and detailed metric properties of patient-reported outcome measures for rheumatoid arthritis: a systematic review covering two decades
por: Küçükdeveci, Ayşe A, et al.
Publicado: (2021)

Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib
por: Bird, Paul, et al.
Publicado: (2019)

Extension Study of PF‐05280586, a Potential Rituximab Biosimilar, Versus Rituximab in Subjects With Active Rheumatoid Arthritis
por: Cohen, Stanley B., et al.
Publicado: (2018)

Randomised study of PF-06410293, an adalimumab (ADL) biosimilar, compared with reference ADL for the treatment of active rheumatoid arthritis: results from weeks 26–52, including a treatment switch from reference ADL to PF-06410293
por: Fleischmann, Roy M, et al.
Publicado: (2021)

Differential expansion of T peripheral helper cells in early rheumatoid arthritis and osteoarthritis synovium
por: Murray-Brown, William, et al.
Publicado: (2022)

Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation
por: Ljung, Lotta, et al.
Publicado: (2018)

Validity and Reliability of Screening Measures for Depression and Anxiety Disorders in Rheumatoid Arthritis
por: Hitchon, Carol A., et al.
Publicado: (2020)

Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritis
por: Tanaka, Yoshiya, et al.
Publicado: (2019)

Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial
por: Balanescu, Andra-Rodica, et al.
Publicado: (2022)

Malignancy risk with tofacitinib versus TNF inhibitors in rheumatoid arthritis: results from the open-label, randomised controlled ORAL Surveillance trial
por: Curtis, Jeffrey R, et al.
Publicado: (2023)

Systematic Literature Review of Residual Symptoms and an Unmet Need in Patients With Rheumatoid Arthritis
por: Michaud, Kaleb, et al.
Publicado: (2021)

Tofacitinib in Combination With Methotrexate in Patients With Rheumatoid Arthritis: Clinical Efficacy, Radiographic, and Safety Outcomes From a Twenty‐Four–Month, Phase III Study
por: van der Heijde, Désirée, et al.
Publicado: (2019)

Increased Burden of Psychiatric Disorders in Rheumatoid Arthritis
por: Marrie, Ruth Ann, et al.
Publicado: (2018)

Randomised, double-blind, phase III study comparing the infliximab biosimilar, PF-06438179/GP1111, with reference infliximab: efficacy, safety and immunogenicity from week 30 to week 54
por: Alten, Rieke, et al.
Publicado: (2019)

Patient-reported outcomes from a phase III study of baricitinib in patients with conventional synthetic DMARD-refractory rheumatoid arthritis
por: Emery, Paul, et al.
Publicado: (2017)

Risk of major adverse cardiovascular events with tofacitinib versus tumour necrosis factor inhibitors in patients with rheumatoid arthritis with or without a history of atherosclerotic cardiovascular disease: a post hoc analysis from ORAL Surveillance
por: Charles-Schoeman, Christina, et al.
Publicado: (2023)

A new classification of HLA-DRB1 alleles based on acid–base properties of the amino acids located at positions 13, 70 and 71: impact on ACPA status or structural progression, and meta-analysis on 1235 patients with rheumatoid from two cohorts (ESPOIR and EAC cohort)
por: Ruyssen-Witrand, Adeline, et al.
Publicado: (2015)

High Adherence to System‐Level Performance Measures for Rheumatoid Arthritis in a National Early Arthritis Cohort Over Eight Years
por: Barber, Claire E. H., et al.
Publicado: (2018)

Rheumatoid Arthritis Naive T Cells Share Hypermethylation Sites With Synoviocytes
por: Rhead, Brooke, et al.
Publicado: (2017)

Internalization of Rituximab and the Efficiency of B Cell Depletion in Rheumatoid Arthritis and Systemic Lupus Erythematosus
por: Reddy, Venkat, et al.
Publicado: (2015)

Immunomics analysis of rheumatoid arthritis identified precursor dendritic cells as a key cell subset of treatment resistance
por: Yamada, Saeko, et al.
Publicado: (2023)

B Cell Synovitis and Clinical Phenotypes in Rheumatoid Arthritis: Relationship to Disease Stages and Drug Exposure
por: Rivellese, F., et al.
Publicado: (2020)

B cell depletion impairs vaccination-induced CD8(+) T cell responses in a type I interferon-dependent manner
por: Graalmann, Theresa, et al.
Publicado: (2021)

Profiling of Gene Expression Biomarkers as a Classifier of Methotrexate Nonresponse in Patients With Rheumatoid Arthritis
por: Plant, Darren, et al.
Publicado: (2019)

Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain Set
por: Bykerk, Vivian P, et al.
Publicado: (2016)

Association Between Genetic Variation in FOXO3 and Reductions in Inflammation and Disease Activity in Inflammatory Polyarthritis
por: Viatte, Sebastien, et al.
Publicado: (2016)

Microbiota‐Dependent Involvement of Th17 Cells in Murine Models of Inflammatory Arthritis
por: Evans‐Marin, Heather, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_t4iqu05luo6h27al8m4e7c6ohj